U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry RACEMIC
Molecular Formula C16H23NO2
Molecular Weight 261.3593
Optical Activity ( + / - )
Defined Stereocenters 3 / 3
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of ETOXADROL, (±)-

SMILES

[H][C@@]1(CO[C@@](CC)(O1)C2=CC=CC=C2)[C@]3([H])CCCCN3

InChI

InChIKey=INOYCBNLWYEPSB-XHSDSOJGSA-N
InChI=1S/C16H23NO2/c1-2-16(13-8-4-3-5-9-13)18-12-15(19-16)14-10-6-7-11-17-14/h3-5,8-9,14-15,17H,2,6-7,10-12H2,1H3/t14-,15+,16-/m0/s1

HIDE SMILES / InChI

Molecular Formula C16H23NO2
Molecular Weight 261.3593
Charge 0
Count
Stereochemistry ABSOLUTE
Additional Stereochemistry No
Defined Stereocenters 3 / 3
E/Z Centers 0
Optical Activity UNSPECIFIED

Targets

Targets

Primary TargetPharmacologyConditionPotency
19.8 null [Ki]
PubMed

PubMed

TitleDatePubMed
Discriminative stimulus and reinforcing properties of etoxadrol and dexoxadrol in monkeys.
1982 Jan

Sample Use Guides

In Vivo Use Guide
0.75 mg/kg
Route of Administration: Intravenous
Substance Class Chemical
Created
by admin
on Sat Dec 16 14:49:12 GMT 2023
Edited
by admin
on Sat Dec 16 14:49:12 GMT 2023
Record UNII
RO44G6QT80
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
ETOXADROL, (±)-
Common Name English
PIPERIDINE, 2-(2-ETHYL-2-PHENYL-1,3-DIOXOLAN-4-YL)-, (2.ALPHA.,4.BETA.(R*))-(±)-
Systematic Name English
Code System Code Type Description
EPA CompTox
DTXSID00865419
Created by admin on Sat Dec 16 14:49:12 GMT 2023 , Edited by admin on Sat Dec 16 14:49:12 GMT 2023
PRIMARY
CAS
30163-01-0
Created by admin on Sat Dec 16 14:49:12 GMT 2023 , Edited by admin on Sat Dec 16 14:49:12 GMT 2023
PRIMARY
PUBCHEM
14208380
Created by admin on Sat Dec 16 14:49:12 GMT 2023 , Edited by admin on Sat Dec 16 14:49:12 GMT 2023
PRIMARY
FDA UNII
RO44G6QT80
Created by admin on Sat Dec 16 14:49:12 GMT 2023 , Edited by admin on Sat Dec 16 14:49:12 GMT 2023
PRIMARY
Related Record Type Details
SALT/SOLVATE -> PARENT